aTYR PHARMA (ATYR) Preferred Shares (2017 - 2019)
aTYR PHARMA's (ATYR) quarterly Preferred Shares came in at $2000.0 in Q4 2019, little changed on a YoY basis from $2000.0 in Q4 2018, and little changed quarter-over-quarter from $2000.0 in Q3 2019.
Analysis
aTYR PHARMA (ATYR) Preferred Shares (2017 - 2019) Analysis & Trends
aTYR PHARMA (ATYR) has reported Preferred Shares for 3 consecutive years, with $2000.0 the latest figure, recorded in Q4 2019.
- For the quarter ending Q4 2019, Preferred Shares changed 0.0% year-over-year to $2000.0; the trailing twelve-month figure through Dec 2019 stood at $2000.0 (changed 0.0% YoY), and the FY2019 full-year result was $2000.0, changed 0.0% from the prior year.
- Preferred Shares was little changed at $2000.0 in Q4 2019 per ATYR's latest filing, from $2000.0 in the prior quarter.
- Across five years, Preferred Shares topped out at $2000.0 in Q3 2017 and bottomed at $2000.0 in Q3 2017.
- Historically, Preferred Shares has averaged $2000.0 across 3 years, with a median of $2000.0 in 2017.
- The widest YoY moves for Preferred Shares: up 0.0% in 2018, down 0.0% in 2018.
- Over 3 years, Preferred Shares stood at $2000.0 in 2017, then changed by 0.0% to $2000.0 in 2018, then changed by 0.0% to $2000.0 in 2019.
- According to Business Quant data, Preferred Shares over the past three periods registered $2000.0, $2000.0, and $2000.0 for Q4 2019, Q3 2019, and Q2 2019 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | - |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | - |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | - |
| 10 | aTYR PHARMA | 35.31 Mn | -22.30 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 2,000.00 |
| Sep 30, 2019 | 2,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Mar 31, 2019 | 2,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Sep 30, 2018 | 2,000.00 |
| Jun 30, 2018 | 2,000.00 |
| Mar 31, 2018 | 2,000.00 |
| Dec 31, 2017 | 2,000.00 |
| Sep 30, 2017 | 2,000.00 |